FUJIFILM Diosynth Biotechnologies is planning to construct a $2 billion biopharmaceutical production facility in Holly Springs, N.C. Enabling large-scale cell culture manufacturing for the creation of bulk drug substances, the structure will accommodate eight 20,000-liter bioreactors with the expansion potential for a further 24 20,000-liter bioreactors to meet market demand. Powered by clean energy, the sustainably designed project will feature advanced systems for waste disposal and recycling. Sophisticated automation technologies will optimize the efficiency of commercial-scale fill/finish, assembly, packaging, and labelling operations. Production will commence at the site in spring of 2025.